Back

Neutralization activity in chronic HIV infection is characterized by a distinct programming of follicular helper CD4 T cells

Moysi, E.; Sharma, A. A.; O'Dell, S.; Georgakis, S.; Del Rio Estrada, P. M.; Torres-Ruiz, F.; Gonzalez Navarro, M.; Luna Villalobos, Y. A.; Avila Rios, S.; Reyes-Teran, G.; Beddall, M. H.; Ko, S.-H.; Belinky, F.; Orfanakis, M.; de Leval, L.; Enriquez, A. B.; Buckner, C. M.; Moir, S.; Doria-Rose, N.; Boritz, E.; Mascola, J. R.; Sekaly, R. P.; Koup, R. A.; Petrovas, C.

2024-08-03 immunology
10.1101/2024.07.31.605954 bioRxiv
Show abstract

A subset of people living with HIV (PLWH) can produce broadly neutralizing antibodies (bNAbs) against HIV, but the lymph node (LN) dynamics that promote the generation of these antibodies are poorly understood. Here, we explored LN-associated histological, immunological, and virological mechanisms of bNAb generation in a cohort of anti-retroviral therapy (ART)-naive PLWH. We found that participants who produce bNAbs, termed neutralizers, have a superior LN-associated B cell follicle architecture compared with PLWH who do not. The latter was associated with a significantly higher in situ prevalence of Bcl-6hi follicular helper CD4 T cells (TFH), expressing a molecular program that favors their differentiation and stemness, and significantly reduced IL-10 follicular suppressor CD4 T cells. Furthermore, our data reveal possible molecular targets mediating TFH-B cell interactions in neutralizers. Together, we identify cellular and molecular mechanisms that contribute to the development of bNAbs in PLWH.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.